Singular Genomics Systems downgraded by UBS with a new price target

8/17/22 9:15:00 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

UBS downgraded Singular Genomics Systems from Buy to Neutral and set a new price target of $4.50 from $10.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OMIC

Date	Price Target	Rating	Analyst
8/17/2022	$10.00 → $4.50	Buy → Neutral	UBS
8/10/2022	$3.50	Buy → Neutral	Goldman
8/10/2022	$3.00	Buy → Underperform	BofA Securities
1/7/2022	$21.00	Neutral → Buy	BofA Securities
10/15/2021		Outperform	Cowen